BlackRock »

Aziyo Biologics shares owned by BlackRock

Quarter-by-quarter ownership of Aziyo Biologics (ELUT) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Aziyo Biologics

Tip: Access up to 7 years of quarterly data

All positions including Aziyo Biologics held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aziyo Biologics by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $273k 72k 3.81

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Aziyo Biologics

Nantahala Capital Management
AIGH Capital Management
Silverarc Capital Management
Birchview Capital
Perkins Capital Management
Alyeska Investment Group
Vanguard Group
Kennedy Capital Management
Geode Capital Management
Eudaimonia Asset Management
BlackRock
Renaissance Technologies
BlackRock
Bank of America Corporation
Arcus Capital Partners

View all funds holding Aziyo Biologics